P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA

P811: PIM2 KINASE REGULATES TIGIT EXPRESSION AND ENERGY METABOLISM IN NK CELLS OF PATIENTS WITH MULTIPLE MYELOMA

Bibliographic Details
Main Authors:	Zhaoyun Liu, Hao Wang, Rong Fu
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000970148.33905.c7

Similar Items

Pim-2 Kinase Regulates Energy Metabolism in Multiple Myeloma
by: Zhaoyun Liu, et al.
Published: (2022-12-01)

An overview of pim kinase as a target in multiple myeloma
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

PIM Kinases in Multiple Myeloma
by: Jian Wu, et al.
Published: (2021-08-01)

Study on the Effect of EZH2 Inhibitor Combined with TIGIT Monoclonal Antibody against Multiple Myeloma Cells
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

PB1794: NATURAL FLAVONOIDS INHIBIT MYELOID NEOPLASM PROLIFERATION BY REGULATING PIM2 KINASE ACTIVITY
by: Hao Wang, et al.
Published: (2023-08-01)

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
by: Teresa Paíno, et al.
Published: (2020-09-01)

Pim Kinases: Important Regulators of Cardiovascular Disease
by: Sophie Nock, et al.
Published: (2023-07-01)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56bright NK cells
by: Annerose E. Ziegler, et al.
Published: (2023-02-01)

TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma
by: Kyle B. Lupo, et al.
Published: (2023-12-01)

Role and Modulation of NK Cells in Multiple Myeloma
by: Marie Thérèse Rubio, et al.
Published: (2021-04-01)

PD1, CTLA4 and TIGIT Expression on T and NK Cells in Granulomatous Diseases: Sarcoidosis and ANCA-Associated Vasculitis
by: Miriana d’Alessandro, et al.
Published: (2022-12-01)

CD155/TIGIT signalling plays a vital role in the regulation of bone marrow mesenchymal stem cell–induced natural killer–cell exhaustion in multiple myeloma
by: Zhao‐Yun Liu, et al.
Published: (2022-07-01)

Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies
by: Dean A Lee, et al.
Published: (2023-12-01)

TIGIT Expression on Activated NK Cells Correlates with Greater Anti-Tumor Activity but Promotes Functional Decline upon Lung Cancer Exposure: Implications for Adoptive Cell Therapy and TIGIT-Targeted Therapies
by: Md Faqrul Hasan, et al.
Published: (2023-05-01)

P827: STUDY ON THE PERCENTAGE AND FUNCTION OF TSCM CELLS AND THE ANTITUMOR EFFECT IN VITRO AMPLIFICATION IN PATIENTS WITH MULTIPLE MYELOMA
by: Panpan Cao, et al.
Published: (2023-08-01)

PIM kinases regulate early human Th17 cell differentiation
by: Tanja Buchacher, et al.
Published: (2023-12-01)

P837: MULTIPLE MYELOMA AND ADJACENT NK CELLS CAN EXPRESS THE MACHINERY TO INTEGRATE NEURONAL SIGNALS
by: Ana Filipa Barahona, et al.
Published: (2023-08-01)

Immune checkpoint inhibitors for multiple myeloma immunotherapy
by: Zhaoyun Liu, et al.
Published: (2023-11-01)

Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma
by: Tatiana Pazina, et al.
Published: (2021-01-01)

PB2136: THE VALUE OF PERIPHERAL BLOOD LYMPHOCYTE SUBSETS IN PREDICTING THE PROGNOSIS OF NEWLY DIAGNOSED MULTIPLE MYELOMA
by: Zhaoyun Liu, et al.
Published: (2023-08-01)

Structure and substrate specificity of the Pim-1 kinase.
by: Bullock, A, et al.
Published: (2005)

Structure and substrate specificity of the Pim-1 kinase
by: Bullock, A, et al.
Published: (2005)

The Role of PIM Kinases in Pediatric Solid Tumors
by: Janet Rae Julson, et al.
Published: (2022-07-01)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
by: Amber N. Clements, et al.
Published: (2022-11-01)

Peptide-based PET imaging agent of tumor TIGIT expression
by: Dinghu Weng, et al.
Published: (2023-05-01)

990 Context dependent effects of TIGIT expression on circulating versus intratumoral NK and CD8 T cells in mouse and human sarcoma models
by: Arta Monjazeb, et al.
Published: (2023-11-01)

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8+ T Cells
by: Xiu-Man Zhou, et al.
Published: (2018-11-01)

Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma
by: Shuxin Huang, et al.
Published: (2022-11-01)

Single VHH-directed BCMA CAR-NK cells for multiple myeloma
by: Quan Ren, et al.
Published: (2023-11-01)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
by: Chantal Reina-Ortiz, et al.
Published: (2022-01-01)

Tumor‐associated macrophages regulate the function of cytotoxic T lymphocyte through PD‐1/PD‐L1 pathway in multiple myeloma
by: Jiangbo Zhang, et al.
Published: (2022-12-01)

PB1778: PAN-PIM KINASE INHIBITOR PIM447 SHOWS SUPERIOR ANTI-LEUKEMIC EFFECT IN ACUTE ERYTHROID LEUKEMIA
by: Chi-Yang Tseng, et al.
Published: (2023-08-01)

Therapeutic strategies to enhance immune response induced by multiple myeloma cells
by: Zhaoyun Liu, et al.
Published: (2023-05-01)

NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment
by: Benjamin Motais, et al.
Published: (2023-11-01)

Expression and Clinical Significance of TIGIT in Primary Breast Cancer
by: Tang L, et al.
Published: (2023-06-01)

Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma
by: Max Von Suskil, et al.
Published: (2021-05-01)

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment
by: Son Hai Vu, et al.
Published: (2023-11-01)

Correction: Conditional Transgenic Expression of PIM1 Kinase in Prostate Induces Inflammation-Dependent Neoplasia
Published: (2013-01-01)

P710: MONOCYTES MEDIATE NK CELL FUNCTION EXHAUSTION IN MDS PATIENTS VIA CD200/CD200R PATHWAY
by: Yixuan Guo, et al.
Published: (2023-08-01)

STUDYING THE ROLE OF PIM KINASES IN FLT3-ITD-INDUCED LEUKEMIA REVEALED PIM1 AS REGULATOR OF CXCL12/CXCR4-MEDIATED HOMING AND MIGRATION
by: Brault, L, et al.
Published: (2009)